BIOMEDCOM CONSULTANTS JOINS LA-SERThe LA-SER Group expands presence in Canada with acquisition of BioMedCom Consultants, complementing U.S. strategic consulting offering
LONDON, UNITED KINGDOM and MONTREAL, CANADA; June 2012—The LA-SER Group, a global leader in health impact assessment and value demonstration of medicines and health technologies, announced today that they have entered into agreement to acquire BioMedCom Consultants. Once finalized, this new partnership will increase the group’s existing pharmacoepidemiology research capabilities in the Canadian market to include health outcomes and health economic research, synchronizing with LA-SER’s strong strategic consulting offering in the United States.
BioMedCom is a consulting firm specializing in the application of health outcomes and health economic research. Experienced research scientists, the founding members of BioMedCom — Donna Rindress PhD, Mireille Goetghebeur PhD, and Sharon Welner PhD — will continue to offer their hands-on approach to ensure the ongoing high quality and value of all their products that their clients have enjoyed for 16 years. The BioMedCom team concentrates on applied outcomes research, including modeling, systematic and literature reviews, health technology value assessment, multicriteria approaches, and strategic reimbursement in the Canadian market andglobally.
“We are excited to soon join together with the LA-SER Analytics teams to grow our service offering in North America. This merger supports our overall mission to advance the ethical and effective use of research information in the broad healthcare community, by leveraging our joint expertise,” – Dr Mireille Goetghebeur.
Over the past year, LA-SER has significantly grown its global presence and capabilities through key strategic acquisitions and mergers. In 2011, the group acquired two health economics consulting companies across Europe and North America—ANALYTICA International, Inc. (United States and Germany) and PBE Consulting (Italy)—and was joined by an organization specialized in patient-related outcomes measures (PROMs)—BAP Health Outcomes (Spain). This year, LA-SER Analytics was also joined by the Poland-based market access consultancy Arcana Institute. LA-SER has consistently evolved to become a global strategic consultancy in population health intelligence applied to medicines.
“The world-class team at BioMedCom is a notable addition to the LA-SER group of companies. LA-SER now offers a full range of specialist skills in North American strategic consulting and decision analytics. We also continue to grow our renowned team of scientific staff through all of these partnerships, allowing us to support the industry in this changing, forward thinking environment of health product assessment.” – Professor Lucien Abenhaim, Chairman, The LA-SER Group.
About The LA-SER Group
The LA-SER Group provides strategic consulting and scientific research services to the pharmaceutical, medical devices and biotech industries. LA-SER’s renowned team is combined of over 200 highly-trained scientific staff, making LA-SER an international leader in the field of population health intelligence. Providing a wide range of evidence-based approaches, proprietary research services and healthcare economics and outcome research (HEOR) consulting capabilities, we support bringing safe and effective treatments to the market. LA-SER is headquartered in the United Kingdom, with offices in eight countries spanning three continents.Contact: Patrizia Berto LA-SER Analytics +390458008609 firstname.lastname@example.org
ARCANA INSTITUTE JOINS THE LA-SER GROUPAddition of Krakow-based Arcana Institute to the LA-SER Group marks a key step in the company’s evolution to becoming a global strategic consultancy in population health intelligence applied to medicines London, United Kingdom and Krakow, Poland; May 2012—The LA-SER Group, a global leader in the evaluation of value and health impact of medicines, today announced that Arcana Institute has joined its group of companies. The addition of market access consultancy Arcana Institute to the LA-SER Group allows for growth in Eastern Europe through a team with a stellar reputation in Poland and international reach in systematic reviews and evidence synthesis.
Founded in 2002, Arcana Institute is directed by Jacek Walczak, Medical Doctor and has grown to a team of fifty. With a focus in Health Technology Assessment (HTA) and systematic reviews, Arcana has made great strides in the Central East Europe (CEE) countries over the past 10 years. “The Arcana team is excited to join LA-SER. Our background in HTA and solid relationships in fundamental emerging CEE countries, combined with the strong scientific leadership and strategic consultancy skills LA-SER , will help us to provide unmatched skills and services to the industry” – Dr Jacek Walczak.
In late 2011, LA-SER acquired two health economics consulting companies across Europe and North America—Analytica International, Inc. (United States and Germany) and PBE Consulting (Italy)—and merged with a company specialized in PROMs—BAP Health Outcomes (Spain)—thus becoming The LA-SER Group. These mergers, combined with recently added Arcana Institute, expand the organization’s capabilities in advanced pharmacoepidemiology research to also encompass strategy consulting, lifecycle decision analytics, health economics, market access, and powerful real-world impact studies.
“LA-SER continues to grow its offering and global reach through strategic partnerships. With Arcana Institute’s solid reputation in Eastern Europe and focus in HTA and systematic reviews of international reach, we are able to expand our footprint and continue to provide our customers with fully integrated solutions,” – Professor Lucien Abenhaim, Chairman, The ANALYTICS LA-SER OUTCOMES Group.
About The LA-SER Group
The LA-SER Group provides strategic consulting and scientific research services to the pharmaceutical, medical devices and biotech industries. LA-SER’s renowned team is combined of over 200 highly-trained scientific staff, making LA-SER an international leader in the field of population health intelligence. Providing a wide range of evidence-based approaches, proprietary research services and healthcare economics and outcome research (HEOR) consulting capabilities, we support bringing safe and effective treatments to the market. LA-SER is headquartered in the United Kingdom, with offices in eight countries spanning three continents.
LA-SER Group Grows Worldwide Healthcare Economics Consulting Capabilities Through Key Strategic Acquisitions; Global Reach Now Spans Three Continents
London; November 2011 – LA-SER announced that the Company significantly expanded its highly specialized worldwide healthcare economics consulting capabilities by entering into agreements to acquire three leading research companies including Analytica International, Inc. (U.S. & Germany), PBE Consulting (Italy)and BAP Health Outcomes / Salumetrics (Spain). Upon closing, LA-SER’s newly combined team will be comprised of over 200 highly-trained scientific staff, making LA-SER an international leader in the field of population health intelligence including a wide range of proprietary research services with a presence in eight countries spanning three continents.
“We are at the beginning of a true revolution in the assessment of health products. The role of “real world studies” are finally being acknowledged with the emergence of a new American and European regulatory and HTA environment. There could not be a better time to build our new and expanded organization, this is why today I am proud and delighted to announce that the LA-SER family has grown to include Analytica International, BAP Health Outcomes / Salumetrics and PBE Consulting’’. – Professor Lucien Abenhaim Chairman, LA-SER.
Analytica International, with its headquarters’ in the United States and Germany brings unique experience and a solid reputation in healthcare economics consulting to the LA-SER group. For over 15 years, Analytica International has provided strategies to optimize reimbursement, pricing, and market access for products and has established solid partnerships with stakeholders, authorities, clients and employees by upholding and maintaining a high standard of integrity.
“Analytica is one of the oldest Health Economics and Outcomes Research consultancies still existing in its original form as founded in 1997. While we have broadened our scope of services and have expanded our footprint, the opportunity to leverage Analytics’ existing service mix and expertise by joining up with a worldwide leader in the pharmaco epidemiology community is in our view an ideal solution to offering our customers the fully integrated capabilities they desire across the spectrum of traditional HEOR services through to real-world evidence generation and comparative/relative effectiveness and risk assessment”. - Roman Casciano, President.
In addition to Analytica International, LA-SER has acquired BAP Health Outcomes / Salumetrics from Spain and PBE Consulting from Italy.
BAP was founded by Pablo Rebollo in 2004 and is specialized in Quality of life studies and psychometric, patient reported outcomes, utility studies and item-response theory. “LA-SER brings together an impressive team of professionals dedicated to real world measurement of the value of health care interventions. This merger will give us an opportunity to serve a larger community worldwide with our QoL and PROMs”. – Pablo Rebollo, Scientific Director.
PBE Consulting was founded by Patrizia Berto in 1997. Patrizia is internationally known as an Italian specialist in market access, with more than 20 years experience in both industry and as a consultant. “I think the Italian Market of consulting & support for healthcare providers, payers and policy makers, will benefit by the presence of a highly specialised & focused international group and PBE is proud to represent a substantial part of this exciting opportunity – Patrizia Berto, President.http://www.la-ser.com/ http://www.analyticaintl.com/ http://www.baphealth.com/ http://www.pbe.it/index.asp?language=ENG&pop=